Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Any Cancer Type”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Early research (Phase 1)Active Not RecruitingNCT04521686
What this trial is testing

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Who this might be right for
CholangiocarcinomaChondrosarcomaGlioma+1 more
Eli Lilly and Company 200
Not applicableActive Not RecruitingNCT04354701
What this trial is testing

COVID-19 and Cancer Consortium Registry

Who this might be right for
COVID-19Invasive Malignancy (Any Type)
Vanderbilt-Ingram Cancer Center 19,275
Not applicableLooking for participantsNCT07612917
What this trial is testing

Brain Connectivity Changes in Glioma Patients During Treatment

Who this might be right for
Glioma (Any Grade) in the BrainGliomas, MalignantfMRI Research+1 more
Johannes Kepler University of Linz 20
Not applicableEnded earlyNCT01169753
What this trial is testing

Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients

Who this might be right for
Chronic Myeloid Leukemia
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00248404
What this trial is testing

NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)

Who this might be right for
Tumors
Kiadis Pharma 155
Not applicableStudy completedNCT00588198
What this trial is testing

Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 754
Testing effectiveness (Phase 2)Study completedNCT02875548
What this trial is testing

Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Synovial Sarcoma+5 more
Epizyme, Inc. 58
Testing effectiveness (Phase 2)Ended earlyNCT04476329
What this trial is testing

Optimization for Regorafenib in HCC

Who this might be right for
Hepatocellular Carcinoma
SC Liver Research Consortium, LLC 7
Early research (Phase 1)Ended earlyNCT01804530
What this trial is testing

Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorTumors of Any Histology With Activating Trk (NTRK) Point or NTRK Fusion MutationsTenosynovial Giant Cell Tumor
Plexxikon 59
Not applicableStudy completedNCT02173171
What this trial is testing

Registry Study for Talimogene Laherparepvec

Who this might be right for
Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial
Amgen 185
Testing effectiveness (Phase 2)Study completedNCT00881946
What this trial is testing

Repeat Dose Safety Study for Compound to Treat Hematologic Cancer

Who this might be right for
Hematologic Malignancies
Accenture 73
Not applicableStudy completedNCT02348957
What this trial is testing

Treating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib

Who this might be right for
Myeloid Leukemia, Chronic, Chronic-Phase
Onco Medical Consult GmbH 223
Testing effectiveness (Phase 2)Study completedNCT00430261
What this trial is testing

Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma

Who this might be right for
Lung CancerAdenocarcinoma
Swedish Medical Center 20
Not applicableStudy completedNCT00967876
What this trial is testing

Coronary Artery Stent Evaluation With 320-slice Computed Tomography - The CArS 320 Study

Who this might be right for
Coronary Artery Stenosis
Charite University, Berlin, Germany 90
Testing effectiveness (Phase 2)WithdrawnNCT03901378
What this trial is testing

Pembrolizumab With Chemotherapy in Metastatic or Unresectable High Grade Gastroenteropancreatic or Lung Neuroendocrine Carcinoma

Who this might be right for
Neuroendocrine CarcinomaLarge Cell Neuroendocrine Carcinoma of the LungHigh Grade Neuroendocrine Carcinoma, Any Site
Ochsner Health System
Not applicableLooking for participantsNCT06375941
What this trial is testing

Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars

Who this might be right for
Angiosarcoma
Italian Sarcoma Group 250
Not applicableNot Yet RecruitingNCT07106008
What this trial is testing

Radiolabeled TSPO Targeted Molecular Probe in Glioma

Who this might be right for
Glioma (Any Grade) in the Brain
Nanjing First Hospital, Nanjing Medical University 8
Not applicableApproved For MarketingNCT03259633
What this trial is testing

An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1

Who this might be right for
NF type1 With Inoperable Plexiform Neurofibromas
AstraZeneca
Testing effectiveness (Phase 2)Study completedNCT03203005
What this trial is testing

IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular Carcinoma
National Cancer Institute, Naples 22
Early research (Phase 1)Study completedNCT01460134
What this trial is testing

CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Who this might be right for
CD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more
Celldex Therapeutics 90
Next Page